Statements (29)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antidote
chelating agent |
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:alsoKnownAs |
gptkb:dimercaprol
|
| gptkbp:ATCCode |
V03AB03
|
| gptkbp:CASNumber |
59-52-9
|
| gptkbp:chemicalFormula |
C3H8As2O2S2
|
| gptkbp:developedBy |
gptkb:United_Kingdom
gptkb:World_War_II |
| gptkbp:discoveredIn |
1940
|
| https://www.w3.org/2000/01/rdf-schema#label |
British anti-Lewisite
|
| gptkbp:meltingPoint |
62 °C
|
| gptkbp:molecularWeight |
202.14 g/mol
|
| gptkbp:relatedTo |
gptkb:lewisite
arsenic compounds |
| gptkbp:sideEffect |
nausea
vomiting hypertension pain at injection site |
| gptkbp:solubility |
insoluble in water
soluble in alcohol |
| gptkbp:usedAs |
antidote to arsenic-based chemical warfare agents
antidote to lewisite poisoning |
| gptkbp:usedFor |
lead poisoning
arsenic poisoning mercury poisoning gold poisoning |
| gptkbp:bfsParent |
gptkb:Dimercaprol
|
| gptkbp:bfsLayer |
6
|